JE, J., & JA, L. (2024). Letter in Response to Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report. The Journal of emergency medicine, 66(2), 262. https://doi.org/10.1016/j.jemermed.2023.10.028
Chicago Style (17th ed.) CitationJE, Jenrette, and Lebin JA. "Letter in Response to Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report." The Journal of Emergency Medicine 66, no. 2 (2024): 262. https://doi.org/10.1016/j.jemermed.2023.10.028.
MLA (9th ed.) CitationJE, Jenrette, and Lebin JA. "Letter in Response to Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report." The Journal of Emergency Medicine, vol. 66, no. 2, 2024, p. 262, https://doi.org/10.1016/j.jemermed.2023.10.028.